Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

Summary Company Announcement Date: August 27, 2026 FDA Publish Date: August 31, 2026 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP) Company Name: Ana Salazar Modela Tu Cuerpo Inc. Brand Name: Brand Name(s) Product Description: Product Description Lipofit Extreme 2.0 Fat Burner Dietary Supplement Company Announcement FOR IMMEDIATE…

B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter

Summary Company Announcement Date: August 27, 2026 FDA Publish Date: August 28, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Presence of particulate matter identified as iron oxide Company Name: B. Braun Medical Inc. Brand Name: Brand Name(s) Product Description: Product Description 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL…

Early Alert: Angiographic Catheter Issue from Boston Scientific

CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available.   Affected Product  The FDA is aware that Boston Scientific has issued a letter to affected customers recommending all Imager II…

Early Alert: IV Start Kit Issue from Avid Medical

CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product The FDA is aware that Avid Medical has issued a letter to affected customers recommending certain convenience kits affected…

Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter

Summary Company Announcement Date: August 25, 2026 FDA Publish Date: August 26, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of particulate matter identified as fiberglass in the solution. Company Name: Baxter International Inc. Brand Name: Brand Name(s) Product Description: Product Description 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic…

Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate Matter

Summary Company Announcement Date: August 25, 2026 FDA Publish Date: August 25, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of particulate matter identified as stainless steel particles in the solution. Company Name: Baxter International Inc. Brand Name: Brand Name(s) Product Description: Product Description 70% Dextrose Injection, USP in 2000 mL…

Early Alert: Nitric Oxide Delivery System Issue from NOxBOX

CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product The FDA is aware that NOxBOX has issued a letter to affected customers recommending certain nitric oxide delivery systems…

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Summary Company Announcement Date: August 19, 2026 FDA Publish Date: August 20, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Elevated Endotoxin level Company Name: Optimal Balance Pharmacy Brand Name: Brand Name(s) Optimal Balance Pharmacy Product Description: Product Description Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial Company Announcement FOR IMMEDIATE RELEASE – August 19,…